Portal vein thrombosis treated using danaparoid sodium and antithrombin III

Hepatogastroenterology. 2010 Jan-Feb;57(97):52-3.

Abstract

A 45-year-old man under treatment for liver cirrhosis (LC) due to chronic hepatitis C and hemophilia A was seen in our emergency room because of a 10-kg weight gain in the previous week due to ascites. Portal vein thrombosis (PVT) was detected with computer tomography (CT) and ultrasonographic (US). Danaparoid sodium (DS) and antithrombin III (AT III) were administrated and doppler US images showed improvement of portal venous blood flow. DS or AT III may be safe and alternative therapies for PVT.

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / therapeutic use*
  • Antithrombin III / therapeutic use*
  • Chondroitin Sulfates / therapeutic use*
  • Dermatan Sulfate / therapeutic use*
  • Fibrinolytic Agents / therapeutic use*
  • Heparitin Sulfate / therapeutic use*
  • Humans
  • Liver Cirrhosis / complications
  • Male
  • Middle Aged
  • Portal Vein*
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / etiology

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Dermatan Sulfate
  • Antithrombin III
  • Chondroitin Sulfates
  • Heparitin Sulfate
  • danaparoid